⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SCYX News
SCYNEXIS, Inc.
Form 8-K
sec.gov
SCYX
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
globenewswire.com
SCYX
Non-Postoperative Pain Management Outlook in Major Markets, 2026-2036 | Industry Poised for Growth as Non-Opioid Therapies and Advanced Drug Delivery Drive Innovation
globenewswire.com
AXSM
BHF
SCYX
Laure-Hélène Mercier cooptée à la Présidence du Conseil d’administration de Poxel
businesswire.com
SCYX
SCYNEXIS to Participate in Upcoming Investor Conferences
globenewswire.com
SCYX
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SCYX
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
SCYX
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
globenewswire.com
SCYX
Form 8-K
sec.gov
SCYX
Form 8-K
sec.gov
SCYX